Gormley W B, Sekhar L N, Wright D C, Kamerer D, Schessel D
Department of Neurological Surgery, George Washington University Medical Center, Washington, District of Columbia, USA.
Neurosurgery. 1997 Jul;41(1):50-8; discussion 58-60. doi: 10.1097/00006123-199707000-00012.
In this article, we review the surgical outcomes of 179 patients with acoustic neuromas.
Most of the tumors (84%) were operated on using a retrosigmoid, transmeatal approach. A transpetrosal, retrosigmoid approach was used in 10% of the patients, most of whom had large tumors. The translabyrinthine (4%) and transmastoid, transpetrosal, partial labyrinthectomy approaches (2%) were used selectively. The operative approaches are discussed. Tumors were categorized according to their cerebellopontine angle dimensions as small (< 2 cm), medium (2.0-3.9 cm), and large (> or = 4 cm).
House-Brackmann evaluation of postoperative facial nerve function revealed excellent results (Grade I or II) in 96% of small tumors, 74% of medium tumors, and 38% of large tumors. A fair postoperative function (Grade III or IV) was achieved in 4% of small tumors, 26% of medium tumors, and 58% of large tumors. Functional hearing preservation, defined as Gardner-Robertson Class I or II, was achieved in 48% of small tumors and 25% of medium tumors. Hearing was not preserved in any of the three patients with large tumors in whom hearing preservation was attempted. Treatment complications consisted mainly of cerebrospinal fluid leakage (15% of the patients). The majority of the patients who experienced cerebrospinal fluid leakage were treated successfully with lumbar spinal drainage; only four patients (2% of the total group) required subsequent surgery for correction of cerebrospinal fluid leakage. There were two deaths (1%) in this series. One death occurred as the result of myocardial infarction and the other as the result of severe obstructive lung disease. One patient sustained disability because of cerebellar and brain stem injury. Complete tumor resection was accomplished in 99% of the patients, and there was no evidence of recurrence in this group. Only 1 of the 179 patients underwent incomplete tumor resection; he required subsequent surgery for symptomatic tumor regrowth. Our patient follow-up had a mean duration of 70 months and a median of 65 months (range, 3-171 mo).
Our results are similar to those of other large microsurgical series of acoustic neuromas. Unless a patient has major medical problems, microsurgery by an experienced team of surgeons is preferred over radiosurgery.
在本文中,我们回顾了179例听神经瘤患者的手术结果。
大多数肿瘤(84%)采用乙状窦后经耳道入路进行手术。10%的患者采用经岩骨乙状窦后入路,其中大多数患者肿瘤较大。选择性地使用了迷路切除术(4%)和经乳突、经岩骨部分迷路切除术(2%)。对手术入路进行了讨论。根据肿瘤的小脑脑桥角大小将肿瘤分为小(<2 cm)、中(2.0 - 3.9 cm)和大(≥4 cm)三类。
House - Brackmann面神经功能术后评估显示,小肿瘤患者中96%结果优秀(I级或II级),中肿瘤患者中74%,大肿瘤患者中38%。小肿瘤患者中4%、中肿瘤患者中26%、大肿瘤患者中58%术后功能为尚可(III级或IV级)。定义为Gardner - Robertson I级或II级的功能性听力保留在小肿瘤患者中占48%,中肿瘤患者中占25%。在尝试保留听力的3例大肿瘤患者中,无一例听力得以保留。治疗并发症主要为脑脊液漏(占患者的15%)。大多数发生脑脊液漏的患者通过腰椎引流成功治疗;只有4例患者(占总患者数的2%)需要后续手术纠正脑脊液漏。本系列中有2例死亡(1%)。1例死于心肌梗死,另1例死于严重阻塞性肺疾病。1例患者因小脑和脑干损伤致残。99%的患者实现了肿瘤全切,且该组无复发迹象。179例患者中只有1例肿瘤切除不完全;他因肿瘤复发出现症状而需要后续手术。我们对患者的随访平均时长为70个月,中位数为65个月(范围3 - 171个月)。
我们的结果与其他大型听神经瘤显微手术系列的结果相似。除非患者有严重的内科问题,由经验丰富的外科团队进行显微手术优于放射外科治疗。